GlassScriptPhysician profile
Robert Frankel
NPI 1548211329
$59,239.77
in general payments reported to CMS, 2019-2025
26 companies · $3,842 in 2025
The $3,842 reported for 2025 was more than what 79% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $6,964 · 2021: $3,732 · 2022: $11K · 2023: $4,759 · 2024: $3,252 · 2025: $3,842.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,525 · Food and Beverage: $4,515 · Travel and Lodging: $2,812.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,525.00 |
| Food and Beverage | $4,515.07 |
| Travel and Lodging | $2,812.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $18,687.11 | 2019-2023 | Brilinta |
| Medtronic Vascular, INC. | $15,962.25 | 2019-2020 | |
| Medtronic, INC. | $13,588.35 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Symplicity G3 |
| Boston Scientific Corporation | $6,160.86 | 2019-2022 | |
| Abbott Laboratories | $1,635.30 | 2019-2025 | Triclip, Mitraclip, Navitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $626.04 | 2019-2025 | Lifevest |
| Edwards Lifesciences Corporation | $550.53 | 2019-2025 | Pascal, Sapien 3 Ultra Resilia |
| Ge Healthcare | $490.20 | 2022 | |
| Philips North America LLC | $351.15 | 2023-2024 | (Bq9) Coronary Ivus, (Bk5) Azurion 5 M20, (Br3) Coronary Other |
| Abiomed | $239.39 | 2019-2023 | Impella |
| Shockwave Medical, INC | $193.64 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Acist Medical Systems, INC. | $131.45 | 2022 | |
| Novo Nordisk INC | $125.00 | 2024 | Wegovy |
| Penumbra, INC. | $98.02 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $76.48 | 2019-2023 | Xarelto |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $73.78 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $51.69 | 2023-2025 | Camzyos, Eliquis |
| Pfizer INC. | $40.24 | 2024-2025 | |
| Irhythm Technologies, INC. | $38.84 | 2019-2020 | |
| Cook Medical LLC | $38.23 | 2019-2025 | Zenith Alpha |
| Sanofi-Aventis U.S. LLC | $21.57 | 2021 | |
| Siemens Medical Solutions USA, INC. | $19.99 | 2022 | |
| W. L. Gore & Associates, INC. | $15.63 | 2024 | Gore Cardioform Septal Occluder |
| Heron Therapeutics, INC. | $15.09 | 2025 | Aponvie |
| Cardiovascular Systems INC. | $8.94 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Frankel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.